NUZ 6.25% 22.5¢ neurizon therapeutics limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-491

  1. 12,310 Posts.
    lightbulb Created with Sketch. 6322
    My preference is to have the CEO in Australia at the helm,,, we have seen the results of Roger being based in the UK , Delays delays delays ,, if he doesn't want to return then its time to begin the search for a new CEO. You don't have the captain of a ship on shore and you don't have a Sargent back at HQ... CEO sets the pace and direction of a company ,,, PAA has been a drift with out a Captain...
    Look at the advancements made by other Biotechs immersed in the same Covid environment ... call it 14 months now waiting for the active ingredient ,, company has totally stalled whilst Roger has been absent...
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.015(6.25%)
Mkt cap ! $109.4M
Open High Low Value Volume
24.0¢ 24.0¢ 22.5¢ $133.9K 573.8K

Buyers (Bids)

No. Vol. Price($)
3 303213 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 57592 2
View Market Depth
Last trade - 15.46pm 18/10/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.